Skip to main content
Premium Trial:

Request an Annual Quote

Althea Technologies and Expression Analysis Team Up for Biomarker Discovery Service

NEW YORK, Oct. 11 (GenomeWeb News) - Althea Technologies of San Diego and Expression Analysis of Durham, NC, will jointly offer a gene expression analysis service to discover biomarkers of disease or drug activity, the companies said today.


The service, called Signature Discovery, will allow researchers to go from global to focused gene expression analysis. It will rely on Expression's experience with Affymetrix's GeneChip technology and Althea's Express Profiling technology.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.